A look at why focusing solely on gross profit margin doesn't make much sense.
Investors should be looking for Microsoft to give details on pricing, support for mobile devices, and Cortana integration.
MannKind may be on the precipice of growth surge thanks to Afrezza, but these three biotech stocks are still growing faster than MannKind.
These 10 stocks were the top large-cap performers in healthcare during 2014.
2014 was a solid year for tech stocks, but not everyone was a winner. A few, led by questionable management teams, struggled. Here are three of 2014's worst tech CEOs.
Microsoft’s Surface Pro could play a key role in the future of the PC and tablet markets.
Microsoft and Accenture's hybrid cloud bundle preserves Microsoft and Accenture's market-leading position among large enterprises.
Google, Apple, and Microsoft dominated tech headlines during the second week of December.
These five names are also growing their revenue faster than Apple.
Intel's manufacturing expertise and research and development spending could give the company a significant advantage over competing chip makers in coming years.